Published in Europace on October 01, 2010
Financial impact of adopting implantable loop recorder diagnostic for unexplained syncope compared with conventional diagnostic pathway in Portugal. BMC Cardiovasc Disord (2014) 0.76
Usefulness of an implantable loop recorder in patients with syncope of an unknown cause. Yonsei Med J (2013) 0.75
[Diagnostics and treatment of syncope]. Z Gerontol Geriatr (2014) 0.75
Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J (2009) 8.25
Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet (2004) 3.02
Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart (2008) 2.85
Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation (2001) 2.49
Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol (2000) 2.20
Indications for the use of diagnostic implantable and external ECG loop recorders. Europace (2009) 2.06
Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J (2003) 1.99
Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation (1999) 1.99
A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J (2005) 1.84
Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation (2001) 1.54
Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation (2001) 1.44
Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J (2006) 1.43
Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. Am J Med (1996) 1.41
The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J (2005) 1.22
Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation (2002) 1.11
Prospective multicentre systematic guideline-based management of patients referred to the Syncope Units of general hospitals. Europace (2010) 1.10
Utility of implantable loop recorder (Reveal Plus) in the diagnosis of unexplained syncope. Europace (2005) 1.00
Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease. Eur Heart J (2004) 0.95
Cardioinhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally mediated syncope. Europace (2007) 0.95
Value of the implantable loop recorder for the management of patients with unexplained syncope. Europace (2004) 0.94
The use of an implantable loop recorder in the investigation of unexplained syncope in older people. Age Ageing (2003) 0.88
Heart rhythm during syncope and presyncope: results of implantable loop recorders. Pacing Clin Electrophysiol (2000) 0.86
Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J (2009) 8.25
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA (2007) 3.32
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol (2010) 3.24
N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol (2005) 3.12
Guidelines on management (diagnosis and treatment) of syncope--update 2004. Europace (2004) 2.47
Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace (2009) 2.33
Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). J Am Coll Cardiol (2006) 2.33
Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years. J Am Coll Cardiol (2006) 2.30
Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. Europace (2008) 2.22
Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation (2011) 2.17
Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol (2002) 2.09
Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res (2007) 2.08
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol (2008) 2.07
Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke (2007) 2.07
Indications for the use of diagnostic implantable and external ECG loop recorders. Europace (2009) 2.06
[The digitalis: should we forget it?]. G Ital Cardiol (Rome) (2008) 2.03
Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. Eur Heart J (2004) 2.01
Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J (2003) 1.99
Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation. J Cardiovasc Med (Hagerstown) (2011) 1.99
Role of early symptoms in assessment of syncope in elderly people: results from the Italian group for the study of syncope in the elderly. J Am Geriatr Soc (2008) 1.97
Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement. Stroke (2004) 1.97
Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. J Am Coll Cardiol (2012) 1.95
Diagnosis and characteristics of syncope in older patients referred to geriatric departments. J Am Geriatr Soc (2006) 1.95
Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol (2002) 1.89
Prognostic stratification of older persons based on simple administrative data: development and validation of the "Silver Code," to be used in emergency department triage. J Gerontol A Biol Sci Med Sci (2009) 1.85
Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization. Europace (2008) 1.85
A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J (2005) 1.84
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2006) 1.84
Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through monte carlo simulations. J Cardiovasc Electrophysiol (2009) 1.84
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J (2008) 1.83
Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J (2011) 1.83
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J (2008) 1.64
Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope. J Cardiovasc Electrophysiol (2011) 1.61
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Rev Esp Cardiol (Engl Ed) (2014) 1.61
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol (2005) 1.56
Acute comparative effect of right and left ventricular pacing in patients with permanent atrial fibrillation. J Am Coll Cardiol (2004) 1.56
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm (2012) 1.54
Association between nocturia and falls-related long-term mortality risk in the elderly. J Am Med Dir Assoc (2012) 1.53
Propagation of the sinus impulse into the Koch triangle and localization, timing, and origin of the multicomponent potentials recorded in this area. Circ Arrhythm Electrophysiol (2011) 1.49
Usefulness and safety of shortened head-up tilt testing potentiated with sublingual glyceryl trinitrate in older patients with recurrent unexplained syncope. J Am Geriatr Soc (2002) 1.47
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace (2012) 1.46
Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. Eur Heart J (2004) 1.46
A complete atrioventricular block secondary to myocardial metastases of lung cancer. A case report. Ital Heart J (2005) 1.44
Restoring sinus rhythm results in blood pressure reduction in patients with persistent atrial fibrillation and a history of hypertension. J Cardiovasc Electrophysiol (2012) 1.43
Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J Cardiovasc Electrophysiol (2005) 1.42
Functional anatomy of aortic regurgitation. Role of transesophageal echocardiography in aortic valve-sparing surgery. Rev Esp Cardiol (2010) 1.38
Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up. Pacing Clin Electrophysiol (2009) 1.37
Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation--ease of use, acceptance, and organizational implications. Pacing Clin Electrophysiol (2008) 1.37
Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study. Eur Heart J (2010) 1.31
A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J (2004) 1.31
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation (2010) 1.31
Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the third International Study on Syncope of Uncertain Etiology (ISSUE-3). Circ Arrhythm Electrophysiol (2013) 1.28
Hypogonadotropic hypogonadism and peripheral neuropathy in Ebf2-null mice. Development (2003) 1.27
Reduced cardiocirculatory complications with unrestrictive visiting policy in an intensive care unit: results from a pilot, randomized trial. Circulation (2006) 1.24
A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace (2012) 1.22
Long-term patient acceptance of and satisfaction with implanted device remote monitoring. Europace (2010) 1.20
Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J (2013) 1.17
Standardized-care pathway vs. usual management of syncope patients presenting as emergencies at general hospitals. Europace (2006) 1.17
Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. J Interv Card Electrophysiol (2008) 1.17
Prognostic implications of right-sided insular damage, cardiac autonomic derangement, and arrhythmias after acute ischemic stroke. Stroke (2005) 1.15
Recurrent unexplained palpitations (RUP) study comparison of implantable loop recorder versus conventional diagnostic strategy. J Am Coll Cardiol (2007) 1.15
Effect of smoking relapse on outcome after acute coronary syndromes. Am J Cardiol (2011) 1.13
From nose to fertility: the long migratory journey of gonadotropin-releasing hormone neurons. Trends Neurosci (2007) 1.12
Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol (2009) 1.12
Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation (2002) 1.11
Prospective multicentre systematic guideline-based management of patients referred to the Syncope Units of general hospitals. Europace (2010) 1.10
Triple-site pacing in patients with biventricular device-incidence of the phenomenon and cardiac resynchronization benefit. J Interv Card Electrophysiol (2004) 1.09
The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum Mol Genet (2004) 1.09
Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. J Am Coll Cardiol (2008) 1.07
Change in atrial activation during orthodromic atrioventricular tachycardia: what is the mechanism? J Cardiovasc Electrophysiol (2002) 1.07
Neuropilins and their ligands are important in the migration of gonadotropin-releasing hormone neurons. J Neurosci (2007) 1.06
Are complications of implantable defibrillators under-estimated and benefits over-estimated? Europace (2009) 1.05
Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur Heart J (2013) 1.04
Coil embolization of coronary artery fistulas. A single-centre experience. Cardiovasc Revasc Med (2008) 1.03